特征追踪衍生的整体纵向应变增强肥厚型心肌病心脏性猝死风险分层
该回顾性研究纳入2009例肥厚型心肌病患者,评估心脏磁共振特征追踪左心室整体纵向应变在现行ESC和ACC/AHA猝死风险模型之外的增量预后价值。中位随访88.2个月,85例(4.2%)发生猝死事件,事件组绝对左心室整体纵向应变显著更低(9.0%±3.6% vs 11.1%±3.6%,P<0.001)。加入该应变后两种模型的5年预测AUC分别从0.72升至0.77、从0.71升至0.76,且绝对应变9.23%阈值可在ICD II类或III类适应证亚组中进一步分层风险。
要点
- 猝死事件组绝对左心室整体纵向应变为9.0%±3.6%,无事件组为11.1%±3.6%(P<0.001)。
- 加入左心室整体纵向应变后ESC模型5年AUC从0.72升至0.77,ACC/AHA模型从0.71升至0.76。
- 绝对应变9.23%阈值可在ICD II类或III类适应证患者中进一步分层猝死风险(log-rank P<0.001)。
核心结论
- 在肥厚型心肌病患者中,心脏磁共振衍生的左心室整体纵向应变是现行指南风险模型之外的猝死增量预测因子,并部分介导心肌异常与猝死之间的关联。
研究设计与样本
- 回顾性分析2009例肥厚型心肌病患者(平均年龄50±14岁,70%为男性),2010年至2017年间接受心脏磁共振检查。
- 左心室整体纵向应变采用电影心脏磁共振特征追踪定量。
- 主要终点包括心脏性猝死和复苏成功的心脏性猝死,采用时间依赖ROC分析和竞争风险回归评估预后效能,并用中介分析探讨应变对心肌肥厚、纤维化与猝死关系的中介作用。
关键影像表现/征象
- 发生猝死事件的患者绝对左心室整体纵向应变显著低于无事件患者(9.0%±3.6% vs 11.1%±3.6%,P<0.001)。
诊断标准与关键数值
- 竞争风险回归中,校正ESC风险因素后左心室整体纵向应变每降低1%的亚分布HR为1.12(95%CI 1.06-1.22,P<0.001)。
- 校正ACC/AHA风险因素后,左心室整体纵向应变每降低1%的亚分布HR为1.09(95%CI 1.02-1.18,P=0.016)。
- 加入左心室整体纵向应变后ESC模型5年预测AUC从0.72升至0.77,ACC/AHA模型从0.71升至0.76。
- 绝对左心室整体纵向应变9.23%阈值可在ICD II类或III类适应证亚组中进一步分层风险(所有log-rank P<0.001)。
- 中介分析显示左心室整体纵向应变部分介导最大室壁厚度和纤维化范围对猝死的影响,中介比例分别为17.5%和23.1%(均P<0.001)。
临床应用与阅片要点
- 在肥厚型心肌病心脏磁共振报告中可定量左心室整体纵向应变,作为现行ESC和ACC/AHA猝死风险模型之外的增量预后信息。
- 绝对左心室整体纵向应变9.23%可作为ICD II类或III类适应证患者进一步风险分层的参考阈值。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Left ventricular (LV)-global longitudinal strain (GLS) assessed by cardiac magnetic resonance (CMR) feature tracking is an emerging marker for predicting adverse outcomes in hypertrophic cardiomyopathy (HCM), but its incremental prognostic value and mechanistic role in sudden cardiac death (SCD) risk stratification remain unclear.
OBJECTIVES: The study sought to evaluate whether LV-GLS adds prognostic value beyond current ESC (European Society of Cardiology) and ACC (American College of Cardiology)/AHA (American Heart Association) SCD risk models, and mediates the relationship between myocardial abnormalities and SCD risk in HCM.
METHODS: The authors retrospectively analyzed 2,009 patients with HCM (mean age: 50 ± 14 years, 70% men) who underwent CMR between 2010 and 2017. LV-GLS was quantified using cine CMR feature tracking. The primary endpoint included SCD and aborted SCD. Prognostic performance was assessed using time-dependent receiver-operating characteristic analysis and competing risk regression. Mediation analysis was used to investigate how LV-GLS mediated associations between myocardial hypertrophy, fibrosis, and SCD.
RESULTS: Over a median follow-up of 88.2 months, 85 (4.2%) patients experienced SCD events. These patients had significantly lower absolute LV-GLS values (9.0% ± 3.6% vs 11.1% ± 3.6%; P < 0.001). In competing-risk regression, LV-GLS independently predicted SCD after adjustment for ESC (subdistribution HR [sHR]: 1.12 per 1% decrease [95% CI: 1.06-1.22]; P < 0.001) and ACC/AHA risk factors (sHR: 1.09 [95% CI: 1.02-1.18]; P = 0.016). Adding LV-GLS improved the 5-year predictive accuracy of both ESC and ACC/AHA models (AUC from 0.72 to 0.77 and from 0.71 to 0.76, respectively). Absolute LV-GLS with a cutoff of 9.23% further stratified risk in patient subgroups with either class II or class III implantable cardioverter-defibrillator indications (all log-rank P < 0.001). Mediation analysis showed LV-GLS partially mediated the effect of maximum wall thickness and extent of fibrosis on SCD (proportion-mediated: 17.5% and 23.1%, respectively; both P < 0.001).
CONCLUSIONS: In patients with HCM, CMR-derived LV-GLS is an incremental predictor of SCD beyond current guideline-based risk models and partially mediates the association between myocardial abnormalities and SCD.
引用
- Ma X, Tang Y, Chen X, et al. Feature Tracking-Derived Global Longitudinal Strain Enhances Risk Stratification for Sudden Cardiac Death in Hypertrophic Cardiomyopathy. JACC Cardiovasc Imaging. 2025. PMID: 41074892. doi:10.1016/j.jcmg.2025.08.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。